CYTR
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Roger MarshallHouse · R · KS |
CYTRCYTR · Stock |
Purchase $1,001 - $15,000 |
Aug 6, 2018 | Jul 31, 2017 | Filing ↗ |
Whale Activity
No 13F positions in CYTR among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Simpson Jennifer K.Director | Grant / award | +25.0K | $0.00 | $0 | Dec 15, 2021 | Form 4 ↗ |
| Brien Earl WDirector | Option exercise | +150.0K | $0.26 | $39K | Aug 14, 2020 | Form 4 ↗ |
| KRIEGSMAN STEVEN AChief Executive Officer · Director | Tax withholding | −1.2M | $0.67 | $780K | Aug 7, 2020 | Form 4 ↗ |
| KRIEGSMAN STEVEN AChief Executive Officer · Director | Option exercise | +3.0M | $0.26 | $780K | Aug 7, 2020 | Form 4 ↗ |
| IGNARRO LOUISDirector | Tax withholding | −271.6K | $0.67 | $182K | Aug 7, 2020 | Form 4 ↗ |
| IGNARRO LOUISDirector | Option exercise | +700.0K | $0.26 | $182K | Aug 7, 2020 | Form 4 ↗ |
| Caldwell Joel KDirector | Tax withholding | −174.6K | $0.67 | $117K | Aug 7, 2020 | Form 4 ↗ |
| Caldwell Joel KDirector | Option exercise | +450.0K | $0.26 | $117K | Aug 7, 2020 | Form 4 ↗ |
| KRIEGSMAN STEVEN ACEO · Director | Grant / award | +387.6K | $1.75 | $678K | Dec 15, 2017 | Form 4 ↗ |
| KRIEGSMAN STEVEN ACEO · Director | Grant / award | +2.3M | $0.43 | $1.0M | Dec 15, 2016 | Form 4 ↗ |
| LEVITT DANIEL JEVP and Chief Medical Officer | Grant / award Amended | +100.0K | $0.00 | $0 | Jan 1, 2014 | Form 4 ↗ |
| LEVITT DANIEL JEVP and Chief Medical Officer | Grant / award Amended | +100.0K | $0.00 | $0 | Jan 1, 2014 | Form 4 ↗ |
| LEVITT DANIEL JEVP and Chief Medical Officer | Grant / award Amended | +100.0K | $0.00 | $0 | Jan 1, 2014 | Form 4 ↗ |
| LEVITT DANIEL JEVP and Chief Medical Officer | Grant / award | +100.0K | $0.00 | $0 | Jan 1, 2014 | Form 4 ↗ |
| Patterson Scott Bradford10% owner | Purchase | −335.0K | $2.40 | $804K | Dec 10, 2013 | Form 4 ↗ |
| Patterson Scott Bradford10% owner | Purchase | +42.1K | $2.35 | $99K | Dec 3, 2013 | Form 4 ↗ |
| Patterson Scott Bradford10% owner | Purchase | +77.1K | $2.39 | $184K | Dec 2, 2013 | Form 4 ↗ |
| Patterson Scott Bradford10% owner | Purchase | +165.7K | $2.48 | $411K | Nov 29, 2013 | Form 4 ↗ |
| Patterson Scott Bradford10% owner | Purchase | +50.0K | $2.06 | $103K | Nov 7, 2013 | Form 4 ↗ |
| Patterson Scott Bradford10% owner | Purchase | +4,083 | $2.70 | $11K | Apr 1, 2013 | Form 4 ↗ |
Fund Holders
Funds report their holdings by CUSIP, and CYTR could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming CYTR as the client.
Government Contracts
No federal contract awards found for CYTR.
U.S. Patents
No USPTO patent applications found for CYTR.
Annual Financials
No annual XBRL figures on record for CYTR. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
No price history on record for CYTR.
Material Events (8-K)
No 8-K filings on record.
About CYTR
No company profile on record.

